Indication
Demoralization
6 registered trials testing LSD, Psilocybin, Ketamine for this indication, 3 recruiting now.
6
Registered trials
3
Recruiting
0
In Phase 3
Substances tested
Being studied with
Stay told
When a new trial opens
Trials
All 6 trials for Demoralization
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| Lysergic Acid Diethylamide (LSD) in Palliative CareNCT05883540 · University Hospital, Basel, Switzerland | Recruiting | Phase 2 | lsd | 4 |
| Pragmatic Trial of Psilocybin Therapy in Palliative CareNCT05403086 · Charles S. Grob, M.D. | Recruiting | Phase 2 | psilocybin, ketamine | 5 |
| Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage CancerNCT06818994 · Gustavo Vazquez | Recruiting | Phase 1 | psilocybin | 1 |
| Ketamine-assisted Therapy for Advanced GI CancerNCT06077487 · Brian Anderson, MD | Terminated | Phase 4 | ketamine | 1 |
| Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice CareNCT04950608 · Yvan Beaussant, MD, MSci | Completed | Phase 2 | psilocybin | 1 |
| Exploratory Study of Low Dose PsilocybinNCT05227742 · University of Alabama at Birmingham | Withdrawn | Early Phase 1 | psilocybin | 1 |
Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.